1. IASO Quiz 2013
Instituted by
Dr Panda and Dr K Gopinath

2. Identify this cancer survivor

3. Identify this cancer survivor
Lance Armstrong

4. Following the 2012 USPSTF
recommendation against PSA screening in
all men, which group saw a decrease in
screening frequency by PCPs?
A. Men between 40-49yrs
B. Men above 79 yrs
C. Patients with previous highest PSA
<2.49ng/ml
D. All the above

5. Following the 2012 USPSTF
recommendation against PSA screening in
all men, which group saw a decrease in
screening frequency by PCPs?
A. Men between 40-49yrs
B. Men above 79 yrs
C. Patients with previous highest PSA
<2.49ng/ml
D. All the above
Cohn JA, et al. Urol Oncol. 2013 Aug 1. [Epub ahead of print]

6. PSA screening is likely to reduce mortality
due to prostate cancer. However the
conclusion is likely to be affected by
A.
B.
C.
D.
Selection Bias
Lead and length Bias
Exposure and measurement issues
All the above

7. PSA screening is likely to reduce mortality
due to prostate cancer. However the
conclusion is likely to be affected by
A.
B.
C.
D.
Selection Bias
Lead and length Bias
Exposure and measurement issues
All the above

8. Urethral Cancer which invades bladder
neck, single inguinal node 3cm is
staged
A.
B.
C.
D.
T4N2M0
T4N1M0
T2N1M0
T3N2M0

9. Urethral Cancer which invades bladder
neck, single inguinal node 3cm is
staged
A.
B.
C.
D.
T4N2M0
T4N1M0
T2N1M0
T3N2M0

10. Micromets play an important role in the
natural progression of urothelial cancer.
What percentage of organ confined node
negative bladder cancers recur following
cystectomy?
A.
B.
C.
D.
25%
5%
40%
60%

11. Micromets play an important role in the
natural progression of urothelial cancer.
What percentage of organ confined node
negative bladder cancers recur following
cystectomy?
A.
B.
C.
D.
25%
5%
40%
60%
Bladder cancer: Diagnosis Therapeutics and Management.
Ed.Cheryl T Lee and David P Wood. 2010 page 89.

12. BCG for superficial bladder cancer can
be potentiated for additional benefit if
combined with which of the following:
A.
B.
C.
D.
Mitomycin C
Interferon
Epirubicin
None of the above

13. BCG for superficial bladder cancer can
be potentiated for additional benefit if
combined with which of the following:
A.
B.
C.
D.
Mitomycin C
Interferon
Epirubicin
None of the above
Zhu S et al. BMC cancer 2013,Jul 5; 13: 322. Pooled results of a recent
meta-analysis of 21 RCT and 9 comparative studiess showed a
better recurrence free survival for BCG+Epirubicin at the cost of an
increase in toxicity.

14. Intravesical BCG for non muscle
invasive bladder cancer for older
patients
A.
B.
C.
D.
Improves Overall Survival
Improves Bladder cancer specific survival
Improves Os but not BCSS
Improves OS and BCSS

15. Intravesical BCG for non muscle
invasive bladder cancer for older
patients
A.
B.
C.
D.
Improves Overall Survival
Improves Bladder cancer specific survival
Improves Os but not BCSS
Improves OS and BCSS
Spencer BA, et al. J Oncol Pract. 2013;9(2):92-98.

16. Name the medicinal Plant/tree/seeds
Supposed to enhance memory

17. Name the medicinal Plant/tree/seeds
Supposed to enhance memory
Ginko biloba

18. The correct statement below is:
A. HPV vaccination is highly effective against
development of cervical dysplasia
B. HPV vaccination is highly effective against
development of anal and cervical dysplasia
C. HPV vaccination is highly effective against
development of cervical, anal and oral
dysplasia

19. The correct statement below is:
A. HPV vaccination is highly effective against
development of cervical dysplasia
B. HPV vaccination is highly effective against
development of anal and cervical dysplasia
C. HPV vaccination is highly effective against
development of cervical, anal and oral
dysplasia
Palefsky et al. NEJM 2011;365(17):1576

20. Vit D receptor Bsm1 polymorphism may
represent a risk factor for _______ women
with ovarian cancer
A.
B.
C.
D.
Asian
North American
European
South American

21. Vit D receptor Bsm1 polymorphism may
represent a risk factor for _______ women
with ovarian cancer
A.
B.
C.
D.
Asian
North American
European
South American
VDR Bsm1 polymorphism is generally no associated with Ovarian
cancer risk. However a subgroup analysis of the study by Qin
X et al ( Int J Gyn Cancer 2013. 23(7): 1178-83) showed
european population to be at risk.

22. Which is not a paraneoplastic
syndrome associated with Lung Cancer
A.
B.
C.
D.
Horner’ syndrome
Lambert-Eaton Syndrome
Sweet’s Syndrome
Dermatomyositis

23. Which is not a paraneoplastic
syndrome associated with Lung Cancer
A.
B.
C.
D.
Horner’ syndrome
Lambert-Eaton Syndrome
Sweet’s Syndrome
Dermatomyositis
The syndrome was first described in 1964 by Dr. Robert D
Sweet. It was also known as Gomm-Button disease in
honour of the first two patients diagnosed. It is
characterized by erythematous well defined cutaneous
papules associates with fever and is associated with
haematologic malignancies like leukaemia, Rheumatoid
Arthritis, IBD, Behcets Syndrome.

24. The dividing line to discriminate 2R
and 4R from 2L and 4L when staging
Lung Cancer is
A. Midline of trachea
B. Right Border of Trachea
C. Left border of Trachea

25. The dividing line to discriminate 2R
and 4R from 2L and 4L when staging
Lung Cancer is
A. Midline of trachea
B. Right Border of Trachea
C. Left border of Trachea

26. Nodal station not amenable to be assessed
by standard cervical mediastinoscopy for
staging lung cancer
A.
B.
C.
D.
Station 3
Station 6
Station 7
Station 5

27. Nodal station not amenable to be assessed
by standard cervical mediastinoscopy for
staging lung cancer
A.
B.
C.
D.
Station 3
Station 6
Station 7
Station 5

28. This 62 yr old pathologist who has
undergone complete resection for a lung
cancer is staged pT2 N0 M0. He asks you
regarding adjuvant therapy with Geftinib.
Your answer is-A. Yes it is beneficial in stage Ib, II and IIIa lung
cancer
B. Adjuvant Geftinib benefits only wild type EGFR
C. Adjuvant Geftinib benefits only mutant EGFR
D. No benefit of Adjuvant Geftinib

29. This 62 yr old pathologist who has
undergone complete resection for a lung
cancer is staged pT2 N0 M0. He asks you
regarding adjuvant therapy with Geftinib.
Your answer is-A. Yes it is beneficial in stage Ib, II and IIIa lung
cancer
B. Adjuvant Geftinib benefits only wild type EGFR
C. Adjuvant Geftinib benefits only mutant EGFR
D. No benefit of Adjuvant Geftinib
Gross GD et al. JCO 2013; 31(17) 3320-26. Trial was stopped mid way due
to lack of benefit

30. Not associated with pleural
Mesothelioma
A.
B.
C.
D.
SV 40 infection
Erionite exposure
Thorium Dioxide therapy
HPV Infection

31. Not associated with pleural
Mesothelioma
A.
B.
C.
D.
SV 40 infection
Erionite exposure
Thorium Dioxide therapy
HPV Infection
Lung Cancer : Prevention, Management and Emerging Therapies. David J
Stewart Ed. 2010; page 437.

32. OCP and HRT use are associated with
increase in breast cancer and Lung
cancer
A. True
B. False

33. OCP and HRT use are associated with
increase in breast cancer and Lung
cancer
A. True
B. False
ILCC pooled analysis of 6 case control studies ( 1961 cases
and 2609 controls) found a reduced risk of lung ca in HRT
(Adeno and Small Cell) and OCP (Squamous CA)users. There
was no dose response relationship with years of OCP/HRT.
Pesatori AC et al. Br J Cancer 2013; 109(7) 1954-64.

34. Which of the following is an inhibitor
of PDGFR
A.
B.
C.
D.
Dasatinib
Vandetanib
Sorafenib
Imatinib

35. Which of the following is an inhibitor
of PDGFR
A.
B.
C.
D.
Dasatinib
Vandetanib Sorafenib
Imatinib
-
VEGFR-2
DS DNA break repair
Bcl-2

36. Name the book by this Ethiopia born
physician which talks of liver
transplantation
A. My Journey
B. Another life
C. Cutting for Stone
D.Emperor’s Malady

37. Name the book by this Ethiopia born
physician which talks of liver
transplantation
A. My Journey
B. Another life
C. Cutting for Stone
D.Emperor’s Malady

38. Does higher UV radiation exposure of
pregnant women reduce incidence of
some childhood cancers
A. Yes
B. No

39. Does higher UV radiation exposure of
pregnant women reduce incidence of
some childhood cancers
A. Yes
•
•
B. No
Lombardi C et al. cancer Epidemiology, Biomarkers and Prevention
2013;22(6): 1118-1128
Results: For cases with UVR exposure of 5,111 Watt-hours/m2 or above, we
estimated a reduction in odds of developing acute lymphoblastic leukemia
(OR: 0.89, 95% CI: 0.81–0.99), hepatoblastoma (OR: 0.69, 95% CI: 0.48–1.00),
and non-Hodgkin's lymphoma (OR: 0.71, 95% CI: 0.50–1.02) adjusting for
mother's age, mother's race, and child's year of birth. We also observed a
small increase in odds for intracranial/intraspinal embryonal tumors (OR: 1.29,
95% CI: 1.01–1.65).
Conclusions: Our findings suggest that UVR during pregnancy may decrease
the odds of some childhood cancers. Future studies should explore additional
factors that may be correlated with UVR exposure and possibly include
biomarkers of immune function and vitamin D.

40. Melanoma subtype which is
characterized by bland fibroblastic
appearance and often mimics a scarA.
B.
C.
D.
Desmoplastic
Acral Letigenous
Nodular
Lentigo maligna

41. Melanoma subtype which is
characterized by bland fibroblastic
appearance and often mimics a scarA.
B.
C.
D.
Desmoplastic
Acral Letigenous
Nodular
Lentigo maligna
DM are strongly and homogeneously positive for S-100 protein but are often
negative or only focally positive for melanocyte differentiation antigens such
as tyrosinase, gp100, Melan-A, and microphthalmia transcription factor. DM
differs from conventional melanoma in its clinical course. It is associated
with a higher tendency for local recurrence, but metastases to regional
lymph nodes are less common.
Wood BA. Pathology 2013; 45(5): 453-463

42. Who is this medical inventor
A. Dr Eric Blom.
B. Dr Robert Esther
C. Dr Douglas J. Schwartzentruber

43. Who is this medical inventor
A. Dr Eric Blom. Inventor of
the Blom Singer Prosthesis
for laryngectomee patients
B. Dr Robert Esther
C. Dr Douglas J. Schwartzentruber
Melanoma Vaccine

44. Pet scan is often advised for follow-up
in patients treated for HNSCC. Which
of the following is correct statement
A. PET scan does not obviate the need for
standard radiology
B. Two negative PET scans at 6 month intervals
obviates the need for additional radiology
C. Single negative PET scan obviates the need
for additional radiology

45. Pet scan is often advised for follow-up
in patients treated for HNSCC. Which
of the following is correct statement
A. PET scan does not obviate the need for
standard radiology
B. Two negative PET scans at 6 month intervals
obviates the need for additional radiology
C. Single negative PET scan obviates the need for
additional radiology
Mc Dermott et al. AJNR 2013; 34(8): 1631-36
The NPV of 2 negative PET scans at 6 month intervals was 98% compared
to 91% for a single negative PET scan

46. Most likely site of an asymptomatic
recurrence of H&N cancer is
A.
B.
C.
D.
Thoracic
Abdominal
Regional nodal
Primary site

47. Most likely site of an asymptomatic
recurrence of H&N cancer is
A.
B.
C.
D.
Thoracic
Abdominal
Regional nodal
Primary site
Dunsky KA et al. Laryngoscope 2013; 123(9): 2161-64

48. H&N Liposarcomas are likely to be
A. Commonly deep and have poor outcome
B. DFS and OS poorer than conventional
liposarcoms
C. Low grade and early stage
D. Deep seated but low grade and stage

49. H&N Liposarcomas are likely to be
A. Commonly deep and have poor outcome
B. DFS and OS poorer than conventional
liposarcoms
C. Low grade and early stage
D. Deep seated but low grade and stage
Gerry D et al. Head and Neck 2013; Jun 01 Epub

50. Stage IVa H&N Melanoma is
A.
B.
C.
D.
T1 N2 M0
T3 N1 M0
T4b N0 M0
T3 N2 M0

51. Stage IVa H&N Melanoma is
A.
B.
C.
D.
T1 N2 M0
T3 N1 M0
T4b N0 M0
T3 N2 M0

52. One of the following is not implicated
in the development of carcinoma of
the larynx.
A.
B.
C.
D.
Tobacco
Leather Dust
Strong Inorganic Mists
Asbestos Dust and Fibre
.

53. One of the following is not implicated
in the development of carcinoma of
the larynx.
A.
B.
C.
D.
Tobacco
Leather Dust
Strong Inorganic Mists
Asbestos Dust and Fibre
Head and Neck CA. Current Perspectives and Challenges. Ed James A
Radosevich. 2013: page 58. The other 3 have a strong association. Others
with limited evidence are HPV 16,18, Sulfur Mustard, Rubber production,
secondary tobacco smoke. Less than 1% are due to alcohol alone.

54. The journey of this physician’s
discovery and clinical application was
captured in a Hollywood movie in
2008 starring Harry Connick A. Living Proof
B. A Gift of Life
C. Nude Rats
D.The Lonely Road

55. The journey of this physician’s
discovery and clinical application was
captured in a Hollywood movie in
2008 starring Harry Connick A. Living Proof
B. A Gift of Life
C. Nude Rats
D.The Lonely Road

56. Triple negative breast cancers typically
demonstrate
A.
B.
C.
D.
Chemotherapy sensitivity
Chemotherapy insensitivity
Sensitive to only cisplatin
Chemotherapy sensitivity followed shorter
durable response

57. Triple negative breast cancers typically
demonstrate
A.
B.
C.
D.
Chemotherapy sensitivity
Chemotherapy insensitivity
Sensitive to only cisplatin
Chemotherapy sensitivity followed shorter
durable response

58. The residual tumour excised at surgery
following neoadjuvant therapy with
Trastuzumab and Chemotherapy is
likely to have -A.
B.
C.
D.
Retained Her2 expression
Gained Her2 point mutations
Lost Her2 expression
Lost Her2 point mutations

59. The residual tumour excised at surgery
following neoadjuvant therapy with
Trastuzumab and Chemotherapy is
likely to have -A.
B.
C.
D.
•
Retained Her2 expression
Gained Her2 point mutations
Lost Her2 expression
Lost Her2 point mutations
In a study of 167 HER2-positive breast cancer patients, participants who received
neoadjuvant chemotherapy without anti-HER2 treatment were more likely to demonstrate
HER2 loss within their residual disease (40% vs 14.7%, P=0.019). Additionally, HER2 loss
demonstrated a trend towards higher risk of relapse (HR 2.41, P=0.063). The pCR is
confirmed as a powerful predictor of long-term outcome. The rate of HER2 loss is higher in
patients receiving neoadjuvant CT without anti-HER2 agents. HER2 status on residual disease
after preoperative therapy can be helpful in selecting patients at different risk of relapse, to
be included in prospective trial exploring further adjuvant therapy.
Guarneri V, et al. Ann Oncol. 2013 Sep 7. [Epub ahead of print]

60. Which of the following predicts the
possibility of recurrence in node
negative breast cancer
A.
B.
C.
D.
Lymphovascular invasion
Age of patient
Perineural spread
Adjuvant radiotherapy

61. Which of the following predicts the
possibility of recurrence in node
negative breast cancer
A.
B.
C.
D.
Lymphovascular invasion
Age of patient
Perineural spread
Adjuvant radiotherapy
In a study of 716 patients with node-negative breast cancer, 47
ultimately recurred during 47 months of median follow-up.
Lymphovascular invasion (HR 4.6) and Nottingham grade 3 (HR 4.99)
tumors were independent risk factors associated with an increased risk
of recurrence. Adjuvant radiotherapy (HR 0.35) decreased tumor
recurrence, while adjuvant chemotherapy had no effect.
Lin PH. J Surg Oncol 2013; 108(6): 352

62. Your 52 yr old patient treated for HR+ EBC
and now on Exemestrane says she is in the
pink of health with no musculoskeletal
symptoms, vasomotor or vulvovaginal
symptoms. Inference on her survival-A. She likely to have a decreased survival
B. No inference can be drawn
C. She has same survival as for her stage of
cancer
D. She is likely to have a better survival

63. Your 52 yr old patient treated for HR+ EBC
and now on Exemestrane says she is in the
pink of health with no musculoskeletal
symptoms, vasomotor or vulvovaginal
symptoms. Inference on her survival-A.
B.
C.
D.
She likely to have a decreased survival
No inference can be drawn
She has same survival as for her stage of cancer
She is likely to have a better survival
Fontein DB et al. JCO 2013; 31(18): 2257-64
International Tamoxifen Exemestrane Multinational Trial

64. The drugs recommended for breast
cancer risk reduction in a 50yr old
postmenopausal lady with family
history of breast cancer and dense
breasts are
A. Raloxifene or Tamoxifen
B. Raloxifene only
C. Raloxifene, Tamoxifen and Exemestrane

65. The drugs recommended for breast
cancer risk reduction in a 50yr old
postmenopausal lady with family
history of breast cancer and dense
breasts are
A. Raloxifene or Tamoxifen
B. Raloxifene only
C. Raloxifene, Tamoxifen and Exemestrane
Moyer VA, et al. Ann Intern Med. 2013 Sep 24. USPSTF recommendations

66. Attachment of H Pylori to the gastric
epithelium leads to activation of NF-Kb
and increased
A. IL-8
B. VEGF
C. MMP-2
D. HGF

67. Attachment of H Pylori to the gastric
epithelium leads to activation of NF-Kb
and increased
A. IL-8
B. VEGF
C. MMP-2
D. HGF

68. Use of S-1 a novel drug based on 5FU with
Cisplatin compared to the standard
Cisplatin + 5FU for gastric cancer reveals
A. Cis plat + S-1 is more effective
B. Increased incidence of Stomatitis, Febrile
neutropenia
C. Lower incidence of hand foot syndrome
D. Increased treatment related deaths

69. Use of S-1 a novel drug based on 5FU with
Cisplatin compared to the standard
Cisplatin + 5FU for gastric cancer reveals
A. Cis plat + S-1 is more effective
B. Increased incidence of Stomatitis, Febrile
neutropenia
C. Lower incidence of hand foot syndrome
D. Increased treatment related deaths
Ajani JA et al. Eur J Cancer 2013; 49(17):3616-24. CS is
noninferior to CF and has improved safety

70. What is not true for follow up of
Stage II and III Colon Cancer
A. 80% recurrences occur in the first 2-2.5 yrs
B. CT abdomen and chest recommended
annually for 3 yrs
C. If surveillance colonoscopy is fine at 1 yr
colonoscopy is done every 2 yrs
D. PET scan can be recommended as part of a
trial only

71. What is not true for follow up of
Stage II and III Colon Cancer
A. 80% recurrences occur in the first 2-2.5 yrs
B. CT abdomen and chest recommended
annually for 3 yrs
C. If surveillance colonoscopy is fine at 1 yr
colonoscopy is done every 2 yrs
D. PET scan can be recommended as part of a
trial only
ASCO endorsed the guideline prepared by CCO ( JCO Nov 2012 )

72. Incorrect about carcinoid tumours
A. Causes depletion of tyrosine
B. Some patients may have dermatological
manifestations in sun exposed parts
C. 10% secrete excessive levels of Serotonin
D. May produce tricuspid stenosis

73. Incorrect about carcinoid tumours
A. Causes depletion of tyrosine. The aminoacid
depleted is tryptophan
B. Some patients may have dermatological
manifestations in sun exposed parts
C. 10% secrete excessive levels of Serotonin
D. May produce tricuspid stenosis

74. This computer scientist and professor at
Carnagie Mellon University was an author
of a best seller called
A. Alice project
B. Time management
C. Achieving your
childhood dreams
D.The last lecture

75. This computer scientist and professor at
Carnagie Mellon University was an author
of a best seller called
A. Alice project
B. Time management
C. Achieving your
childhood dreams
D.The last lecture by
Randy Pausch

76. The 5 year survival of stage 1
pancreatic cancer is-A.
B.
C.
D.
Less than 30%
50%
65%
5%

77. The 5 year survival of stage 1
pancreatic cancer is-A.
B.
C.
D.
Less than 30%
50%
65%
5%

78. In patients with nonfunctioning pancreatic
neuroendocrine tumors (NF-PanNETs), when
preoperative grading assessment is not
achieved, which clinical variable is an excellent
predictor of post-treatment nodal positivity?
A.
B.
C.
D.
Radiological tumour size
BMI
Age
Gender

79. In patients with nonfunctioning pancreatic
neuroendocrine tumors (NF-PanNETs), when
preoperative grading assessment is not
achieved, which clinical variable is an excellent
predictor of post-treatment nodal positivity?
A.
B.
C.
D.
Radiological tumour size
BMI
Age
Gender
Partelli S, et al. JAMA Surg. 2013;148(10):932-939.

80. In patients with hepatocellular carcinoma
(HCC) receiving transarterial therapy
(TACE/TAE), which is NOT a prognostic
factor for risk of death?
A.
B.
C.
D.
Albumin > 3.6 g/dl
Bilirubin > 17umol/l
Tumour Size > 7 cm
AFP >400ng/dl

81. In patients with hepatocellular carcinoma
(HCC) receiving transarterial therapy
(TACE/TAE), which is NOT a prognostic
factor for risk of death?
A.
B.
C.
D.
Albumin > 3.6 g/dl
Bilirubin > 17umol/l
Tumour Size > 7 cm
AFP >400ng/dl
This is the hepatoma arterial embolization prognostic score.
Kadalayil L, et al. Ann Oncol. 2013;24(10):2565-2570.

82. For adult survivors of childhood cancer,
which organ system is the most at-risk for
disease during adulthood after exposure to
treatment with potential toxicity?
A.
B.
C.
D.
Pulmonary
Haematopoietic
Hepatic
Gastrointestinal
.

83. For adult survivors of childhood cancer,
which organ system is the most at-risk for
disease during adulthood after exposure to
treatment with potential toxicity?
A.
B.
C.
D.
Pulmonary
Haematopoietic
Hepatic
Gastrointestinal
Less than 15% develop haematopoietic, hepatic, skeletal
dysfunction. Other organs at risk are cardiac, neurologic,
neurocognitive and endocrine.
Hudson MM, et al. JAMA. 2013;309(22):2371-2381.

84. What percentage of adult survivors of
childhood cancer develop an adult
neoplasm (benign and or malignant)
A.
B.
C.
D.
16%
45%
3%
0.5%

85. What percentage of adult survivors of
childhood cancer develop an adult
neoplasm (benign and or malignant)
A.
B.
C.
D.
16%
45%
3%
0.5%
Hudson MM, et al. JAMA. 2013;309(22):2371-2381.

86. This actor was diagnosed with ---- in
the film
A. Leukaemia
B. Brain Tumour
C. Lymphosarcoma
of Intestine

87. Risk of recurrence in GIST after surgery
is high (55% or more)in all except:
A.
B.
C.
D.
More than 10 cm size in any location
2-5cm with mitosis 5 per 50HPF
Mucosal invasion
Mitosis >1 per 5HPF

88. Risk of recurrence in GIST after surgery
is high (55% or more)in all except:
A.
B.
C.
D.
More than 10 cm size in any location
2-5cm with mitosis 5 per 50HPF
Mucosal invasion
Mitosis >1 per 5HPF

89. Most of the GIST are positive for CD117.
Approximately 8% are CD117 negative but
PDGFRA positive. These tumours areA. Clinically indolent, located in small intestine
B. Clinically aggressive, located in stomach and
C. Clinically indolent, located in stomach,

90. Most of the GIST are positive for CD117.
Approximately 8% are CD117 negative but
PDGFRA positive. These tumours areA. Clinically indolent, located in small intestine
B. Clinically aggressive, located in stomach and
C. Clinically indolent, located in stomach
Haematology Oncology Clinics: Rare Cancers. Dec 2012.
These PDGFRA positive tumours commonly are of epithelioid
morphology and the commonest mutation is on exon 18 (D842V) which
makes them resistant to TKI

91. The expected DFS following non
operative management of clinical CR
of Stage I-III rectal cancer treated by
neoadjuvant CCRT is
A.
B.
C.
D.
50%
80%
60%
40%

92. The expected DFS following non
operative management of clinical CR
of Stage I-III rectal cancer treated by
neoadjuvant CCRT is
A.
B.
C.
D.
50%
80%
60%
40%
Solanki AA et al. Onco Targets and therapy 2013; 2013(6): 1097-1110

93. Who is this surgeon
A.Frank H. Netter
B.B Fisher
C.CW Lilliehei

94. Who is this surgeon
A. Frank H. Netter was an American
surgeon and celebrated medical
illustrator. The first edition of his
Atlas of Human Anatomy — his
"personal Sistine Chapel" — was
published in 1989 and he was made
a Fellow of the New York Academy
of Medicine
B. B Fisher
C. CW Lilliehei

95. Statistics: the incorrect statement is
A. Type 1 error is fixed apriori
B. Increasing sample size has no effect on type 2
error
C. Doubling sample size does not affect
confidence interval
D. Sample size and effect size are inversely
related

96. Statistics: the incorrect statement is
A. Type 1 error is fixed apriori
B. Increasing sample size has no effect on type
2 error
C. Doubling sample size does not affect
confidence interval
D. Sample size and effect size are inversely
related

97. Which is not a subtypes of Chondroma
A.
B.
C.
D.
Ectochondroma
Enchondroma
Perosteal chondroma
Soft tissue Chondroma

98. Which is not a subtypes of Chondroma
A.
B.
C.
D.
Ectochondroma
Enchondroma
Perosteal chondroma
Soft tissue Chondroma

99. What minimum dose of radiation is
needed to produce a statistically
superior response to bone pain
A.
B.
C.
D.
10 Gy
8 Gy
15 Gy
4 Gy

100. What minimum dose of radiation is
needed to produce a statistically
superior response to bone pain
A.
B.
C.
D.
10 Gy
8 Gy
15 Gy
4 Gy
Dennis K. Radiother Oncol 2013; 106(1) 5-14
In this systematic analysis the authors found that the minimum dose of
8Gy was needed to reduce pain in bone mets.

101. Most common Uterine Sarcoma
A.
B.
C.
D.
Carcinosarcoma
Endometrial stromal sarcoma
Leiomyosarcoma
Adenosarcoma

102. Most common Uterine Sarcoma
A.
B.
C.
D.
Carcinosarcoma
Endometrial stromal sarcoma
Leiomyosarcoma
Adenosarcoma

103. He hypothesised the angiogenesis theory
for cancer which states that a tumor is able
to create its own blood supply. Dozens of
cancer drugs were developed based on his
research.
A.
B.
C.
D.
Dr J Michael Bishop
Dr Harold E Varmus
Dr Judah Folkman
Dr Brian J Druker

104. He hypothesised the angiogenesis theory
for cancer which states that a tumor is able
to create its own blood supply. Dozens of
cancer drugs were developed based on his
research.
A. Dr J Michael Bishop
B. Dr Harold E Varmus
Nobel for Oncogene 1989
C. Dr Judah Folkman
D. Dr Brian J Druker
Along with Nicholas B. Lydon and
Charles Sawyers, Lasker for CML